FOLD vs UHS · rev $528.3M vs P/E 5.9, rev $9.13B
Amicus Therapeutics Inc (FOLD) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
FOLD currently screens at market cap $1.80B. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the FOLD and UHS stock pages for the full models.
Not investment advice.